CLEVELAND--(BUSINESS WIRE)--Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its panel of inflammation biomarkers will be featured at next week’s TEDMED 2012 conference in Washington. The annual conference, being held April 10-13, explores the issues, challenges and innovations that are shaping the future of health and medicine.
